Louisiana 2010 Regular Session

Louisiana Senate Bill SSR2

Caption

Requests the Senate committees on revenue and fiscal affairs and health and welfare to jointly study the effects of local sales tax on prescription drugs administered in an outpatient setting.

Impact

If conducted, this study could provide essential insights into the financial implications of local sales and use taxes on prescription drugs, especially given that Louisiana is one of the few states that permits such taxation. The findings could highlight disparities across the state, influencing future legislation concerning local tax authority and its interruptive effects on healthcare delivery. Furthermore, it could reinforce arguments for potential reforms in sales tax policy that align with broader public health goals, bolstering access to vital medications without the burden of excess financial strain on healthcare providers.

Summary

Senate Study Request No. 2 (SSR2) proposes a comprehensive study to analyze the fiscal impact of local sales taxes imposed on prescription drugs administered in outpatient settings such as physician's offices and infusion clinics. It targets the effects of these taxes across all sixty-four parishes in Louisiana and seeks to understand how local taxation influences healthcare access and overall costs for both providers and patients. The impetus for this study arises amid growing concerns regarding the impact of local taxing authorities on prescription medications that are exempt from state taxes under the Louisiana Constitution.

Sentiment

The sentiment surrounding SSR2 is mainly constructive, aiming to inform and facilitate dialogue around a pressing healthcare funding concern. Though specific opposition or contention details have not been highlighted in the immediate discussions, there is an underlying acknowledgment of the importance of addressing such local tax issues within the broader context of healthcare policy and affordability. Stakeholders may include healthcare providers concerned about the financial impact of local taxes and local taxing authorities managing their revenue needs.

Contention

While there is a general agreement on the necessity for such a study, potential points of contention could arise around the outcomes and recommendations it generates. For instance, if the analysis reveals significant adverse effects of local taxation on access to medicines, it may lead to calls for legislation to restrict or eliminate such taxes, potentially triggering disagreements among local governments that rely on this revenue. The nuances of healthcare financing and taxability could lead to varied opinions on the balance between generating local revenue and ensuring equitable access to healthcare services.

Companion Bills

No companion bills found.

Previously Filed As

LA HSR4

Requests the House Committee on Ways and Means and the House Committee on Health and Welfare to study the effects of local sales taxes on prescription drugs administered in an outpatient setting

LA SR97

Requests study of the effects of local sales tax on complex biologics administered in a physician's office, infusion clinic, or outpatient setting.

LA HB629

Exempts from local sales and use taxes certain prescription drugs administered by topical system in medical clinics (EN DECREASE LF RV See Note)

LA HB1404

Provides for a local sales and use tax exemption for the procurement or administration of certain prescription drugs (EG DECREASE LF RV See Note)

LA SB129

Exempts certain infused or injected prescription drugs from local sales tax. (7/1/22) (EN DECREASE LF RV See Note)

LA HCSR4

Requests the House Committee on Ways and Means and the Senate Committee on Revenue and Fiscal Affairs to study the effects of a sales and use tax exemption for feminine hygiene products and diapers

LA HB107

Provides for a local sales and use tax exemption for the procurement or administration of certain prescription drugs (OR DECREASE LF RV See Note)

LA HB249

Exempts prescription drugs and insulin from local sales and use taxes (EG DECREASE LF RV See Note)

LA HB1203

Beginning Jan. 1, 2014, exempts prescription drugs and pharmacists services from local sales and use taxes (EG -$125,000,000 LF RV See Note)

LA HB326

Makes technical corrections to various provisions of law within the purview of the legislative committees on health and welfare

Similar Bills

No similar bills found.